Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this article we will analyze whether IVERIC bio, Inc. (NASDAQ:ISEE) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
San Diego-based Shoreline Biosciences, a developer of cell immunotherapies for treating solid tumors and hematologic malignancies, has raised $140M in a financing round, the company said today. The fu
Gilead Sciences and BeiGene, which started research alliances with Shoreline Biosciences earlier this year, are among the investors in the biotech's latest financing. The preclinical-stage company technology develops cell therapies for cancer by using natural killer cells.